BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31130394)

  • 1. Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.
    Tracey LJ; Justice MJ
    Trends Genet; 2019 Jul; 35(7):489-500. PubMed ID: 31130394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRDM14: a unique regulator for pluripotency and epigenetic reprogramming.
    Nakaki F; Saitou M
    Trends Biochem Sci; 2014 Jun; 39(6):289-98. PubMed ID: 24811060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-option of the PRDM14-CBFA2T complex from motor neurons to pluripotent cells during vertebrate evolution.
    Kawaguchi M; Sugiyama K; Matsubara K; Lin CY; Kuraku S; Hashimoto S; Suwa Y; Yong LW; Takino K; Higashida S; Kawamura D; Yu JK; Seki Y
    Development; 2019 Jan; 146(2):. PubMed ID: 30630825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specification of the germ cell lineage in mice: a process orchestrated by the PR-domain proteins, Blimp1 and Prdm14.
    Kurimoto K; Yamaji M; Seki Y; Saitou M
    Cell Cycle; 2008 Nov; 7(22):3514-8. PubMed ID: 19001867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRDM14-CtBP1/2-PRC2 complex regulates transcriptional repression during the transition from primed to naïve pluripotency.
    Yamamoto M; Suwa Y; Sugiyama K; Okashita N; Kawaguchi M; Tani N; Matsubara K; Nakamura A; Seki Y
    J Cell Sci; 2020 Aug; 133(15):. PubMed ID: 32661086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRDM14 Is a Unique Epigenetic Regulator Stabilizing Transcriptional Networks for Pluripotency.
    Seki Y
    Front Cell Dev Biol; 2018; 6():12. PubMed ID: 29487849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation.
    Nady N; Gupta A; Ma Z; Swigut T; Koide A; Koide S; Wysocka J
    Elife; 2015 Nov; 4():e10150. PubMed ID: 26523391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
    Carofino BL; Ayanga B; Justice MJ
    Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
    Ji J; Cao J; Chen P; Huang R; Ye SD
    J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
    Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
    Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
    Dettman EJ; Simko SJ; Ayanga B; Carofino BL; Margolin JF; Morse HC; Justice MJ
    Oncogene; 2011 Jun; 30(25):2859-73. PubMed ID: 21339739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRDM14, a Zinc Finger Protein, Regulates Cancer Stemness.
    Taniguchi H; Imai K
    Methods Mol Biol; 2018; 1867():3-13. PubMed ID: 30155811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline development in rat revealed by visualization and deletion of
    Kobayashi T; Kobayashi H; Goto T; Takashima T; Oikawa M; Ikeda H; Terada R; Yoshida F; Sanbo M; Nakauchi H; Kurimoto K; Hirabayashi M
    Development; 2020 Feb; 147(4):. PubMed ID: 32001439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.
    Imai K; Taniguchi H
    Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(7):325-335. PubMed ID: 35908955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
    Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K
    Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagic homeostasis is required for the pluripotency of cancer stem cells.
    Sharif T; Martell E; Dai C; Kennedy BE; Murphy P; Clements DR; Kim Y; Lee PW; Gujar SA
    Autophagy; 2017 Feb; 13(2):264-284. PubMed ID: 27929731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells.
    Mallol A; Guirola M; Payer B
    Epigenetics Chromatin; 2019 Jun; 12(1):38. PubMed ID: 31221220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted DamID reveals differential binding of mammalian pluripotency factors.
    Cheetham SW; Gruhn WH; van den Ameele J; Krautz R; Southall TD; Kobayashi T; Surani MA; Brand AH
    Development; 2018 Oct; 145(20):. PubMed ID: 30185410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.